679 results on '"Young-Wolff, Kelly C."'
Search Results
2. A patient activation intervention in primary care for patients with chronic pain on long term opioid therapy: results from a randomized control trial
- Author
-
Does, Monique B., Adams, Sara R., Kline-Simon, Andrea H., Marino, Catherine, Charvat-Aguilar, Nancy, Weisner, Constance M., Rubinstein, Andrea L., Ghadiali, Murtuza, Cowan, Penney, Young-Wolff, Kelly C., and Campbell, Cynthia I.
- Published
- 2024
- Full Text
- View/download PDF
3. Associations between Adverse Childhood Experiences (ACEs) and Prenatal Mental Health and Substance Use.
- Author
-
Foti, Tara R, Watson, Carey, Adams, Sara R, Rios, Normelena, Staunton, Mary, Wei, Julia, Sterling, Stacy A, Ridout, Kathryn K, and Young-Wolff, Kelly C
- Subjects
Humans ,Substance-Related Disorders ,Cross-Sectional Studies ,Anxiety ,Mental Health ,Pregnancy ,Female ,Adverse Childhood Experiences ,adverse childhood experiences ,mental health ,perinatal health ,pregnancy ,resilience ,screening ,substance use ,Behavioral and Social Science ,Clinical Research ,Violence Against Women ,Brain Disorders ,Depression ,Pediatric ,Pediatric Research Initiative ,Violence Research ,2.3 Psychological ,social and economic factors ,Aetiology ,Mental health ,Reproductive health and childbirth ,Good Health and Well Being ,Peace ,Justice and Strong Institutions ,Toxicology - Abstract
Adverse childhood experiences (ACEs) are common and increase the risk of poor health outcomes. Resilience may offer protection against the impacts of ACEs. This study examined the association between maternal ACEs and mental/behavioral health outcomes during pregnancy overall and by resilience. The sample comprised pregnant patients in two pilot studies screened for eight ACEs and resilience during standard prenatal care in Kaiser Permanente Northern California from 1 March 2016 to 30 July 2016 (Study 1, medical centers A, B) and from 1 April 2018 to 31 March 2019 (Study 2, medical centers A, C). Early pregnancy outcomes included anxiety and depressive disorders, depression symptoms, intimate partner violence (IPV), and substance use. Multivariable logistic regression was used in this cross-sectional study to examine associations between maternal ACEs (0, 1-2, ≥3) and mental/behavioral health outcomes overall and among those with low and high resilience. Patients (n = 1084) averaged 30.8 years (SD 5.1); 41.7% were non-Hispanic White; 41.7% experienced ≥1 ACE, and 40.3% had low resilience. Patients with 1-2 ACEs or ≥3 ACEs (versus 0 ACEs) had higher odds of anxiety and depressive disorders, depressive symptoms, IPV, and any prenatal substance use (OR 1.44-4.40, p < 0.05). Each individual ACE was associated with ≥2 mental/behavioral health outcomes. In stratified analyses, having ≥1 ACE (vs. 0) was associated with a greater number of mental/behavioral health outcomes among patients with low versus high resilience. ACEs were associated with prenatal mental/behavioral health conditions, particularly in the context of low resilience, highlighting the importance of trauma-informed prenatal care and the need to study resilience-building interventions during pregnancy.
- Published
- 2023
4. Current tobacco smoking and risk of SARS-CoV-2 infection and hospitalization: Evaluating the role of socio-demographic factors and comorbidities.
- Author
-
Young-Wolff, Kelly C, Slama, Natalie, Sakoda, Lori C, Prochaska, Judith J, Fogelberg, Renee, and Alexeeff, Stacey E
- Subjects
Humans ,Cardiovascular Diseases ,Diabetes Mellitus ,Hospitalization ,Risk Factors ,Retrospective Studies ,Comorbidity ,Adult ,Tobacco Smoking ,COVID-19 ,SARS-CoV-2 ,Ethnicity ,Age ,Comorbidities ,Nicotine ,Race ,Smoking ,Tobacco ,Pneumonia & Influenza ,Tobacco Smoke and Health ,Infectious Diseases ,Prevention ,Pneumonia ,Vaccine Related ,Lung ,Cardiovascular ,Good Health and Well Being ,Human Movement and Sports Sciences ,Public Health and Health Services ,Public Health - Abstract
Our recently published study of >2.4 million adults in Northern California indicated that current versus never-tobacco smoking was associated with lower risk of SARS-CoV-2 infection and less severe coronavirus disease 2019 (COVID-19). We extended this research by evaluating whether these associations were moderated by socio-demographic factors and medical comorbidities. This retrospective cohort study of 1,885,826 adults with current or never-smoking status in Kaiser Permanente Northern California from 3/5/2020 (baseline) to 12/31/2020 (pre-vaccine) included electronic health record-based socio-demographics (sex, age, race/ethnicity, neighborhood deprivation index (NDI)) and medical comorbidities (obesity, cardiovascular conditions, diabetes, renal disease, respiratory conditions). We estimated the adjusted risk of SARS-CoV-2 infection and hospitalization (≤30 days of infection) associated with smoking status using Cox proportional hazard regression models. We estimated associations within subgroups of socio-demographics and comorbidities, and tested for effect modification using interaction terms. During the study, 35,627 patients had SARS-CoV-2 infection. Current versus never-smoking status was associated with lower adjusted rates of SARS-CoV-2 infection (aHR ranging from 0.51 to 0.89) and hospitalization (aHR ranging from 0.32 to 0.70) within nearly every socio-demographic and comorbidity subgroup. Statistically significant interactions showed that the magnitude of protection for SARS-CoV-2 infection varied by sex, age, race/ethnicity, NDI, cardiovascular conditions and diabetes, and for SARS-CoV-2 hospitalization by age and renal disease. Taken together, results indicated that while some socio-demographics and comorbidities moderated the associations, the lower risk of SARS-CoV-2 infection and hospitalization associated with current versus never-smoking status persisted among patients regardless of socio-demographics or comorbidities.
- Published
- 2023
5. Association of cannabis use during pregnancy with severe acute respiratory syndrome coronavirus 2 infection: a retrospective cohort study
- Author
-
Young‐Wolff, Kelly C, Ray, G Thomas, Alexeeff, Stacey E, Benowitz, Neal, Adams, Sara R, Does, Monique B, Goler, Nancy, Ansley, Deborah, Conway, Amy, and Avalos, Lyndsay A
- Subjects
Public Health ,Health Sciences ,Substance Misuse ,Pediatric ,Prevention ,Lung ,Emerging Infectious Diseases ,Infectious Diseases ,Pneumonia ,Clinical Research ,Reproductive health and childbirth ,Infection ,Good Health and Well Being ,Humans ,Female ,Pregnancy ,COVID-19 ,SARS-CoV-2 ,COVID-19 Testing ,Cannabis ,Retrospective Studies ,Pregnancy Complications ,Infectious ,marijuana ,pregnancy ,prenatal ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Substance Abuse ,Public health ,Clinical and health psychology - Abstract
Background and aimsCannabis use is increasingly common among pregnant individuals and might be a risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We aimed to test whether prenatal cannabis use is associated with increased risk of SARS-CoV-2 infection during pregnancy.DesignThis is a retrospective cohort study.SettingThe study was conducted in California, USA.ParticipantsA total of 58 114 pregnancies (with outcomes from 5 March 2020 to 30 September 2021) among 57 287 unique pregnant women aged 14-54 years who were screened for prenatal substance use, enrolled in Kaiser Permanente Northern California (KPNC) (a health-care system) and had not tested positive for COVID-19 prior to pregnancy onset.MeasurementsWe utilized data from the KPNC electronic health record. Cannabis use status (current, recently quit and non-user) was based on universal screenings during prenatal care (including urine toxicology testing and self-reported use on a self-administered questionnaire). SARS-CoV-2 infection [based on polymerase chain reaction (PCR) tests] was estimated in time-to-event analyses using Cox proportional hazard regression models adjusting for covariates. Secondary analyses examined differences in (a) SARS-CoV-2 testing rates and (b) SARS-CoV-2 infection rates among those tested.FindingsWe observed 348 810 person-months of follow-up time in our cohort with 41 064 SARS-CoV-2 PCR tests and 6% (n = 2414) of tests being positive. At the start of follow-up, 7% of pregnant individuals had current use, 12% had recently quit and 81% did not use cannabis. Adjusting for covariates, current use was associated with lower rates of SARS-CoV-2 infection [adjusted hazard ratio (aHR) = 0.60, 95% confidence interval (CI) = 0.49-0.74 than non-use. Those who had recently quit did not differ from non-cannabis users in infection rates (aHR = 0.96, 95% CI = 0.86-1.08). Sensitivity analyses among patients who received a SARS-CoV-2 test also found lower odds of infection associated with current versus no cannabis use (aOR = 0.76, CI = 0.61-0.93).ConclusionsCurrent cannabis use appears to be associated with a reduced risk of SARS-CoV-2 infection among pregnant individuals.
- Published
- 2023
6. Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease Severity Among Adults in an Integrated Healthcare System in California
- Author
-
Young-Wolff, Kelly C, Slama, Natalie, Alexeeff, Stacey E, Sakoda, Lori C, Fogelberg, Renee, Myers, Laura C, Campbell, Cynthia I, Adams, Alyce S, and Prochaska, Judith J
- Subjects
Health Services and Systems ,Health Sciences ,Vaccine Related ,Immunization ,Tobacco ,Prevention ,Coronaviruses ,Infectious Diseases ,Clinical Research ,Emerging Infectious Diseases ,Tobacco Smoke and Health ,Infection ,Respiratory ,Good Health and Well Being ,Humans ,Adult ,COVID-19 Testing ,Cohort Studies ,Retrospective Studies ,COVID-19 ,SARS-CoV-2 ,Tobacco Smoking ,California ,Patient Acuity ,Hospitalization ,Delivery of Health Care ,Integrated ,Clinical Sciences ,Public Health and Health Services ,Marketing ,Public Health ,Epidemiology ,Public health - Abstract
IntroductionThe relationship between tobacco smoking status and SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) severity is highly debated. We conducted a retrospective cohort study of >2.4 million adults in a large healthcare system to evaluate whether smoking is associated with SARS-CoV-2 infection and disease severity.Aims and methodsThis retrospective cohort study of 2,427,293 adults in KPNC from March 5, 2020 (baseline) to December 31, 2020 (pre-vaccine) included smoking status (current, former, never), socio-demographics, and comorbidities from the electronic health record. SARS-CoV-2 infection (identified by a positive PCR test) and COVID-19 severity (hospitalization, ICU admission or death ≤ 30 days of COVID-19 diagnosis) were estimated in time-to-event analyses using Cox proportional hazard regression models adjusting for covariates. Secondary analyses examined COVID-19 severity among patients with COVID-19 using logistic regression.ResultsDuring the study, 44,270 patients had SARS-CoV-2 infection. Current smoking was associated with lower adjusted rates of SARS-CoV-2 infection (aHR = 0.64 95% CI: 0.61-0.67), COVID-19-related hospitalization (aHR = 0.48 95% CI: 0.40-0.58), ICU admission (aHR = 0.62 95% CI: 0.42-0.87), and death (aHR = 0.52 95% CI: 0.27-0.89) than never-smoking. Former smoking was associated with a lower adjusted rate of SARS-CoV-2 infection (aHR = 0.96 95% CI: 0.94-0.99) and higher adjusted rates of hospitalization (aHR = 1.10 95% CI: 1.03-1.08) and death (aHR = 1.32 95% CI: 1.11-1.56) than never-smoking. Logistic regression analyses among patients with COVID-19 found lower odds of hospitalization for current versus never-smoking and higher odds of hospitalization and death for former versus never-smoking.ConclusionsIn the largest US study to date on smoking and COVID-19, current and former smoking showed lower risk of SARS-CoV-2 infection than never-smoking, while a history of smoking was associated with higher risk of severe COVID-19.ImplicationsIn this cohort study of 2.4 million adults, adjusting for socio-demographics and medical comorbidities, current tobacco smoking was associated with a lower risk of both SARS-CoV-2 infection and severe COVID-19 illness compared to never-smoking. A history of smoking was associated with a slightly lower risk of SARS-CoV-2 infection and a modestly higher risk of severe COVID-19 illness compared to never-smoking. The lower observed COVID-19 risk for current versus never-smoking deserves further investigation. Results support prioritizing individuals with smoking-related comorbidities for vaccine outreach and treatments as they become available.
- Published
- 2023
7. Electronic cigarette use and risk of COVID-19 among young adults without a history of cigarette smoking
- Author
-
Young-Wolff, Kelly C, Slama, Natalie E, Alexeeff, Stacey E, Prochaska, Judith J, Fogelberg, Renee, and Sakoda, Lori C
- Subjects
Epidemiology ,Public Health ,Health Sciences ,Substance Misuse ,Prevention ,Clinical Research ,Tobacco Smoke and Health ,Tobacco ,Good Health and Well Being ,COVID-19 ,Cigarette Smoking ,Electronic Nicotine Delivery Systems ,Humans ,Retrospective Studies ,Smoking Cessation ,Vaping ,Young Adult ,Electronic cigarette ,SARS-CoV-2 ,e -cigarette ,e-cigarette ,Human Movement and Sports Sciences ,Public Health and Health Services ,Public health - Abstract
It is unknown whether use of e-cigarettes increases susceptibility to COVID-19. In a large clinical sample of young adults, we evaluated whether current or ever e-cigarette use was associated with polymerase chain reaction (PCR)-confirmed COVID-19. To address the confounding of combustible smoking, the sample was restricted to never smokers. This retrospective cohort study analyzed data from the electronic health records of 74,853 young adults (aged 18-35 years), without a history of cigarette smoking, who were screened for e-cigarette use (current, former, never) in the Kaiser Permanente Northern California (KPNC) healthcare system from 3/5/2020 (baseline) to 11/30/2020 (pre-vaccine). COVID-19 risk was estimated in time-to-event analyses using multivariable Cox proportional hazard regression models, adjusted for socio-demographics and medical comorbidities. E-cigarette status in the cohort was: 1.6% current, 1.2% former, and 97.2% never. During follow-up, 1965 (2.6%) patients acquired COVID-19. We did not find evidence that current (vs never) e-cigarette use was associated with risk of COVID-19 (aHR = 1.12 95%CI:0.77-1.62). However, we did find suggestive evidence that former (versus never) e-cigarette use may be associated with greater risk of COVID-19 (aHR = 1.39 95%CI:0.98-1.96). While e-cigarette use is associated with health risks for young adults, results from this study suggest that current use of e-cigarettes may not increase susceptibility for COVID-19 among young adults who have never smoked cigarettes.
- Published
- 2022
8. Prevalence and trends of suspected cannabinoid hyperemesis syndrome over an 11-year period in Northern California: An electronic health record study
- Author
-
Costales, Brianna, Lu, Yun, Young-Wolff, Kelly C., Cotton, Dale M., Campbell, Cynthia I., Iturralde, Esti, and Sterling, Stacy A.
- Published
- 2024
- Full Text
- View/download PDF
9. Racial, ethnic, and neighborhood socioeconomic disparities in local cannabis retail policy in California
- Author
-
Simard, Bethany J, Padon, Alisa A, Silver, Lynn D, Avalos, Lyndsay A, Soroosh, Aurash J, and Young-Wolff, Kelly C
- Published
- 2024
- Full Text
- View/download PDF
10. Clinician perspectives on adolescent cannabis-related beliefs and behaviors following recreational cannabis legalization
- Author
-
Young-Wolff, Kelly C., Does, Monique B., Mian, Maha N., Sterling, Stacy A., Satre, Derek D., Campbell, Cynthia I., Silver, Lynn D., Alexeeff, Stacey E., Cunningham, Sarah F., Asyyed, Asma, and Altschuler, Andrea
- Published
- 2024
- Full Text
- View/download PDF
11. Association of Pregnancy Intentions With Substance Use During Early Pregnancy
- Author
-
Young-Wolff, Kelly C, Slama, Natalie, Sarovar, Varada, Conway, Amy, Tucker, Lue-Yen, Goler, Nancy, Terplan, Mishka, Ansley, Deborah, Adams, Sara R, and Armstrong, Mary Anne
- Subjects
Public Health ,Health Sciences ,Pediatric Research Initiative ,Conditions Affecting the Embryonic and Fetal Periods ,Contraception/Reproduction ,Prevention ,Clinical Research ,Pediatric ,Substance Misuse ,Brain Disorders ,Reproductive health and childbirth ,Good Health and Well Being ,Female ,Humans ,Intention ,Pregnancy ,Pregnancy ,Unplanned ,Pregnant Women ,Prenatal Care ,Substance-Related Disorders ,health care ,pregnancy intentions ,prenatal ,screening ,substance use ,Public Health and Health Services ,Substance Abuse ,Public health ,Clinical and health psychology - Abstract
ObjectivesThe goal of this study was to evaluate the association between pregnancy intentions and substance use in early pregnancy among pregnant women receiving prenatal care in a large, integrated healthcare system.MethodsThe sample comprised 29,787 Kaiser Permanente Northern California pregnant women (12.1% aged
- Published
- 2022
12. Why do Americans use marijuana?
- Author
-
Kurtzman, Ellen T and Young-Wolff, Kelly C
- Subjects
Public Health ,Health Sciences ,Drug Abuse (NIDA only) ,Cannabinoid Research ,Prevention ,Substance Misuse ,Good Health and Well Being ,Aged ,Cannabis ,Hallucinogens ,Humans ,Illicit Drugs ,Marijuana Smoking ,Marijuana Use ,Medical Marijuana ,United States ,Young Adult ,Behavioral Risk Factor Surveillance System ,Health policy ,Marijuana use ,Substance abuse ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Substance Abuse ,Biochemistry and cell biology ,Pharmacology and pharmaceutical sciences ,Epidemiology - Abstract
BackgroundMarijuana is the most commonly used illicit drug in the United States; yet, little is known about why adults use it. We examined the prevalence of past-month marijuana use by users' reasons for use-medical, recreational, and both-and identified correlates of each group.MethodsData from 20 states, which participated in the 2017-2019 Behavioral Risk Factor Surveillance System and fielded the marijuana use module, and multinomial logistic regression analysis were used to identify risk factors for past-month marijuana use by reason for use. User profiles were developed to illustrate how states' policy environments influenced reported reasons for use.ResultsThe average predicted probabilities of past-month marijuana use for medical, recreational, and both reasons were 28.6 %, 38.2 %, and 33.1 %, respectively. Age, gender, marital and employment status, income, mode and frequency of administration, and health status were associated with reasons for use. The reasons that young adult males who were infrequent marijuana users and binge drinkers gave for their marijuana use varied by state policy environment-in legal states, the average predicted probabilities were 5.3 % lower for recreational reasons and 5.0 % higher for both reasons. Reported reasons for past-month marijuana use did not significantly differ by state policy environment among daily users who were older women in poor mental and physical health.DiscussionSignificant differences existed in the characteristics of past-month marijuana users by reasons for use. Our estimates can serve as a baseline against which post-legalization marijuana users' reasons for use can be compared as state policy environments shift.
- Published
- 2021
13. Cannabis Use Among Patients With Psychotic Disorders.
- Author
-
Hirschtritt, Matthew E, Young-Wolff, Kelly C, Mathalon, Daniel H, and Satre, Derek D
- Subjects
Health Services and Systems ,Health Sciences ,Serious Mental Illness ,Cannabinoid Research ,Mental Health ,Clinical Research ,Brain Disorders ,Substance Misuse ,Mental health ,Good Health and Well Being ,Analgesics ,Cannabidiol ,Cannabis ,Humans ,Marijuana Abuse ,Psychotic Disorders ,Health services and systems - Abstract
Amidst a rapidly changing legal landscape, cannabis use in the United States has become increasingly common in the past several years. There is strong evidence to suggest that chronic and early cannabis use increases the risk of developing a psychotic disorder, and there is at least moderate evidence that suggests ongoing cannabis use among individuals with a psychotic disorder worsens clinical outcomes (eg, decreased psychiatric medication adherence, more frequent psychiatric hospitalizations). In this Review Article, we provide a focused, clinically oriented overview of the epidemiology and characteristics of cannabis use among individuals with first-episode psychosis; evaluation of cannabis use; and treatment modalities, focusing on behavioral interventions suitable for outpatient primary care settings. We discuss the limited data supporting pharmacologic interventions for cannabis use disorder, specifically among individuals with first-episode psychosis, and the unique potential of cannabidiol to serve as a harm-reduction strategy for individuals who are not able or willing to achieve abstinence for cannabis.
- Published
- 2021
14. Nicotine and cannabis vaping among adolescents in treatment for substance use disorders.
- Author
-
Young-Wolff, Kelly C, Adams, Sara R, Sterling, Stacy A, Tan, Andy SL, Salloum, Ramzi G, Torre, Kira, Carter-Harris, Lisa, and Prochaska, Judith J
- Subjects
Humans ,Cannabis ,Substance-Related Disorders ,Nicotine ,Adolescent ,Female ,Male ,Vaping ,Electronic Nicotine Delivery Systems ,Addiction treatment ,Adolescents ,E-cigarette ,Substance Misuse ,Clinical Research ,Brain Disorders ,Drug Abuse (NIDA only) ,Pediatric Research Initiative ,Tobacco Smoke and Health ,Tobacco ,Behavioral and Social Science ,Mental health ,Good Health and Well Being ,Public Health and Health Services ,Psychology ,Substance Abuse - Abstract
This study examined nicotine and cannabis vaping among adolescents in treatment for substance use disorders. Participants were 363 adolescents aged 12-17 (66% male, mean age = 15.5 [SD = 1.3], 46% non-Hispanic white) seen for a specialty addiction intake evaluation between 2017 and 2019 at one of six medical offices of a large, integrated health care system in Northern California. Multivariable logistic regression models tested for associations of sociodemographics, cigarette smoking, and substance use disorders with vaping behaviors. A majority of adolescents reported ever (68%) or current vaping (60%) of nicotine and/or cannabis; current vaping was similar for nicotine (50%) and cannabis (51%); 40% reported current vaping of both. Current smokers (6% of the sample) had higher odds of ever vaping (aOR = 3.95, 95%CI: 1.04-14.95). Black (versus non-Hispanic white) adolescents had lower odds of current nicotine vaping (aOR = 0.08, 95%CI: 0.02-0.37) and current vaping of both nicotine and cannabis (aOR = 0.12, 95%CI: 0.03-0.60). Having an alcohol use disorder was associated with current vaping (aOR = 2.14, 95%CI: 1.06-4.33). Those who endorsed that most friends get drunk/high (aOR = 1.87, 95%CI: 1.02-3.42) or that cannabis was their substance of choice (aOR = 2.36, 95%CI: 1.16-4.81) had higher odds of current cannabis vaping. Higher neighborhood household income ($80,000-$120,000 and >$120,000 vs.
- Published
- 2021
15. Exploring preferences for different modes of cannabis use during early pregnancy: A qualitative study
- Author
-
Mian, Maha N., Foti, Tara R., Green, Andrea, Iturralde, Esti, Altschuler, Andrea, Does, Monique B., Jackson-Morris, Melanie, Adams, Sara R., Satre, Derek D., Ansley, Deborah, and Young-Wolff, Kelly C.
- Published
- 2023
- Full Text
- View/download PDF
16. Adverse Childhood Experiences and Pregnancy Intentions among Pregnant Women Seeking Prenatal Care
- Author
-
Young-Wolff, Kelly C, Wei, Julia, Varnado, Nicole, Rios, Normelena, Staunton, Mary, and Watson, Carey
- Subjects
Midwifery ,Health Sciences ,Pediatric ,Reproductive health and childbirth ,Good Health and Well Being ,Adverse Childhood Experiences ,Child ,Female ,Humans ,Intention ,Pregnancy ,Pregnancy ,Unwanted ,Pregnant Women ,Prenatal Care ,Paediatrics and Reproductive Medicine ,Public Health and Health Services ,Public Health ,Public health ,Policy and administration - Abstract
BackgroundThis study examined whether adverse childhood experiences (ACEs) are associated with increased risk of having an unwanted or mistimed pregnancy.MethodsWomen in two medical centers within an integrated health system were screened for ACEs during standard prenatal care (N = 745). Multinomial multivariable logistic regression analyses examined the associations of ACEs (count and type) with pregnancy intentions, adjusting for covariates.ResultsOverall, 58.3% of pregnant women reported no ACEs, 19.1% reported one ACE, and 22.7% reported two or more ACEs; 76.2% reported wanting to get pregnant, 18.5% reported wanting to get pregnant but not at this time (i.e., mistimed pregnancy), and 5.2% reported not wanting to get pregnant at all (i.e., unwanted pregnancy). Having two or more (vs. 0) ACEs was associated with higher odds of an unwanted pregnancy (odds ratio, 2.60; 95% confidence interval, 1.19-5.68). Further, childhood loss of parent (odds ratio, 2.20; 95% confidence interval, 1.03-4.71) and neglect (odds ratio, 5.67; 95% confidence interval, 1.72-18.72) were each associated with higher odds of an unwanted pregnancy in separate analyses. ACEs count and type were not significantly associated with having a mistimed pregnancy.ConclusionsAmong women screened for ACEs during standard prenatal care, ACEs were associated with increased odds of having an unwanted pregnancy, but not a mistimed pregnancy. Additional research is needed to better understand the mechanisms through which ACEs and other individual, social, and contextual factors impact pregnancy intentions to better support women and provide appropriate resources to help prevent unintended pregnancies.
- Published
- 2021
17. Association of Cannabis Retailer Proximity and Density With Cannabis Use Among Pregnant Women in Northern California After Legalization of Cannabis for Recreational Use.
- Author
-
Young-Wolff, Kelly C, Adams, Sara R, Padon, Alisa, Silver, Lynn D, Alexeeff, Stacey E, Van Den Eeden, Stephen K, and Avalos, Lyndsay A
- Published
- 2021
18. Smoking cessation treatment for individuals with comorbid diabetes and serious mental illness in an integrated health care delivery system
- Author
-
Hwong, Alison R, Schmittdiel, Julie, Schillinger, Dean, Newcomer, John W, Essock, Susan, Zhu, Zheng, Dyer, Wendy, Young-Wolff, Kelly C, and Mangurian, Christina
- Subjects
Health Services and Systems ,Public Health ,Health Sciences ,Health Services ,Cardiovascular ,Brain Disorders ,Serious Mental Illness ,Mental Health ,Schizophrenia ,Prevention ,Tobacco Smoke and Health ,Clinical Research ,Clinical Trials and Supportive Activities ,Tobacco ,Diabetes ,Respiratory ,Mental health ,Good Health and Well Being ,Adult ,Delivery of Health Care ,Diabetes Mellitus ,Type 2 ,Humans ,Mental Disorders ,Retrospective Studies ,Smoking Cessation ,Serious mental illness ,Smoking cessation ,Public Health and Health Services ,Psychology ,Substance Abuse ,Public health ,Biological psychology ,Clinical and health psychology - Abstract
IntroductionSmoking is a significant modifiable risk factor for mortality for persons with serious mental illness (SMI), who have a life expectancy 15-20 years shorter than the general population. Individuals with SMI and comorbid diabetes who are smokers face an even higher risk of cardiovascular complications and early death. Yet despite high rates of smoking among people with SMI, tobacco cessation interventions have not been broadly offered to this population.MethodsWe conducted a retrospective cohort study using electronic health records from 2014 in a large integrated care delivery system to examine whether use of smoking cessation pharmacotherapy among smokers with type 2 diabetes varies by serious mental illness (SMI) diagnosis. We analyzed smoking cessation medication prescription fills among adult smokers with diabetes, comparing those with SMI (N = 634) and without SMI (N = 18,021). Risk ratios were adjusted for age, gender, race, urban area type, and medical facility.ResultsOf the SMI group, 19.09% filled at least one smoking cessation prescription compared to 9.73% of the non-SMI group (adjusted risk ratio 1.80 [95% CI 1.52-2.13]; p
- Published
- 2021
19. The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system
- Author
-
Satre, Derek D, Levine-Hall, Tory, Sterling, Stacy A, Young-Wolff, Kelly C, Lam, Jennifer O, Alexeeff, Stacey, Hojilla, J Carlo, Williams, Andrew, Justice, Amy C, Sterne, Jonathan, Cavassini, Matthias, Bryant, Kendall J, Williams, Emily C, Horberg, Michael A, Volberding, Paul, Weisner, Constance, and Silverberg, Michael J
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Alcoholism ,Alcohol Use and Health ,Health Services ,Infectious Diseases ,Tobacco Smoke and Health ,HIV/AIDS ,Tobacco ,Clinical Research ,Substance Misuse ,Behavioral and Social Science ,Minority Health ,Prevention ,Sexually Transmitted Infections ,Cancer ,Stroke ,Cardiovascular ,Good Health and Well Being ,Adult ,Alcohol Drinking ,Continuity of Patient Care ,Delivery of Health Care ,Integrated ,Female ,HIV Infections ,Humans ,Male ,Middle Aged ,Primary Health Care ,Smoking ,Tobacco Smoking ,Alcohol ,Primary care ,Integrated health care ,HIV care continuum ,Viral control ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Substance Abuse ,Biochemistry and cell biology ,Pharmacology and pharmaceutical sciences ,Epidemiology - Abstract
IntroductionSmoking tobacco and unhealthy alcohol use may negatively influence HIV care continuum outcomes but have not been examined in combination.MethodsParticipants were people with HIV (PWH) in Kaiser Permanente Northern California. Predictors included smoking status and unhealthy alcohol use (exceeding daily and/or weekly limits) reported by patients during primary care screening (index date). Outcomes were based on not achieving the following steps in the care continuum: linkage to HIV care (≥1 visit within 90 days of newly identified HIV diagnosis), retention (2+ in-person visits, 60+ days apart) and HIV RNA control (
- Published
- 2021
20. COVID-19 prevalence, symptoms, and sociodemographic disparities in infection among insured pregnant women in Northern California
- Author
-
Ames, Jennifer L, Ferrara, Assiamira, Avalos, Lyndsay A, Badon, Sylvia E, Greenberg, Mara B, Hedderson, Monique M, Kuzniewicz, Michael W, Qian, Yinge, Young-Wolff, Kelly C, Zerbo, Ousseny, Zhu, Yeyi, and Croen, Lisa A
- Subjects
Reproductive Medicine ,Health Services and Systems ,Biomedical and Clinical Sciences ,Health Sciences ,Behavioral and Social Science ,Prevention ,Clinical Research ,Aetiology ,2.4 Surveillance and distribution ,Reproductive health and childbirth ,Good Health and Well Being ,Adolescent ,Adult ,COVID-19 ,COVID-19 Testing ,California ,Electronic Health Records ,Female ,Hispanic or Latino ,Humans ,Pandemics ,Pregnancy ,Pregnant Women ,SARS-CoV-2 ,Self Report ,Socioeconomic Factors ,Surveys and Questionnaires ,White People ,Young Adult ,General Science & Technology - Abstract
BackgroundResearch on COVID-19 during pregnancy has mainly focused on women hospitalized for COVID-19 or other reasons during their pregnancy. Little is known about COVID-19 in the general population of pregnant women.ObjectiveTo describe the prevalence of COVID-19, symptoms, consequent healthcare use, and possible sources of COVID-19 exposure among a population-based sample of pregnant women residing in Northern California.MethodsWe analyzed data from 19,458 members of Kaiser Permanente Northern California who were pregnant between January 2020 and April 2021 and responded to an online survey about COVID-19 testing, diagnosis, symptoms, and their experiences during the COVID-19 pandemic. Medical diagnosis of COVID-19 during pregnancy was defined separately by self-report and by documentation in electronic health records (EHR). We examined relationships of COVID-19 with sociodemographic factors, underlying comorbidities, and survey measures of COVID-19-like symptoms, consequent healthcare utilization, and possible COVID-19 exposures.ResultsAmong 19,458 respondents, the crude prevalence of COVID-19 was 2.5% (n = 494) according to self-report and 1.4% (n = 276) according to EHR. After adjustment, the prevalence of self-reported COVID-19 was higher among women aged
- Published
- 2021
21. Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study
- Author
-
Satre, Derek D, Parthasarathy, Sujaya, Silverberg, Michael J, Horberg, Michael, Young-Wolff, Kelly C, Williams, Emily C, Volberding, Paul, and Campbell, Cynthia I
- Subjects
Health Services and Systems ,Health Sciences ,Women's Health ,Infectious Diseases ,Prevention ,HIV/AIDS ,Sexually Transmitted Infections ,Clinical Research ,Health Services ,Good Health and Well Being ,California ,Delivery of Health Care ,Integrated ,HIV Infections ,Health Services Accessibility ,Humans ,Insurance Coverage ,Longitudinal Studies ,Patient Acceptance of Health Care ,Patient Protection and Affordable Care Act ,United States ,Health care reform ,Deductibles ,Affordable Care Act ,AIDS Drug Assistance Program ,Insurance ,Mental health ,HIV viral suppression ,Race ,ethnicity ,Race/ethnicity ,Library and Information Studies ,Nursing ,Public Health and Health Services ,Health Policy & Services ,Health services and systems ,Public health - Abstract
BackgroundThe Affordable Care Act (ACA) has increased insurance coverage for people with HIV (PWH) in the United States. To inform health policy, it is useful to investigate how enrollment through ACA Exchanges, deductible levels, and demographic factors are associated with health care utilization and HIV clinical outcomes among individuals newly enrolled in insurance coverage following implementation of the ACA.MethodsAmong PWH newly enrolled in an integrated health care system (Kaiser Permanente Northern California) in 2014 (N = 880), we examined use of health care and modeled associations between enrollment mechanisms (enrolled in a Qualified Health Plan through the California Exchange vs. other sources), deductibles (none, $1-$999 and > = $1000), receipt of benefits from the California AIDS Drug Assistance Program (ADAP), demographic factors, and three-year patterns of health service utilization (primary care, psychiatry, substance treatment, emergency, inpatient) and HIV outcomes (CD4 counts; viral suppression at HIV RNA
- Published
- 2020
22. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system
- Author
-
Satre, Derek D, Palzes, Vanessa A, Young-Wolff, Kelly C, Parthasarathy, Sujaya, Weisner, Constance, Guydish, Joseph, and Campbell, Cynthia I
- Subjects
Health Services and Systems ,Health Sciences ,Health Disparities ,Mental Health ,Brain Disorders ,Prevention ,Clinical Research ,Drug Abuse (NIDA only) ,Health Services ,Minority Health ,Substance Misuse ,Women's Health ,Emergency Care ,8.1 Organisation and delivery of services ,Mental health ,Good Health and Well Being ,California ,Delivery of Health Care ,Humans ,Patient Acceptance of Health Care ,Patient Protection and Affordable Care Act ,Substance-Related Disorders ,United States ,Affordable Care Act ,Substance use disorder ,Race/ethnic disparities ,Health insurance ,Deductible ,Public Health and Health Services ,Psychology ,Substance Abuse ,Health services and systems ,Clinical and health psychology - Abstract
BackgroundPractitioners expected the Affordable Care Act (ACA) to increase availability of health services and access to treatment for Americans with substance use disorders (SUDs). Yet research has not examined the associations among ACA enrollment mechanisms, deductibles, and the use of SUD treatment and other healthcare services. Understanding these relationships can inform future healthcare policy.MethodsWe conducted a longitudinal analysis of patients with SUDs newly enrolled in the Kaiser Permanente Northern California health system in 2014 (N = 6957). Analyses examined the likelihood of service utilization (primary care, specialty SUD treatment, psychiatry, inpatient, and emergency department [ED]) over three years after SUD diagnosis, and associations with enrollment mechanisms (ACA Exchange vs. other), deductibles (none, $1-$999 [low] and ≥$1000 [high]), membership duration, psychiatric comorbidity, and demographic characteristics. We also evaluated whether the enrollment mechanism moderated the associations between deductible limits and utilization likelihood.ResultsService utilization was highest in the 6 months after SUD diagnosis, decreased in the following 6 months, and remained stable in years 2-3. Relative to patients with no deductible, those with a high deductible had lower odds of using all health services except SUD treatment; associations with primary care and psychiatry were strongly negative among Exchange enrollees. Among non-Exchange enrollees, patients with deductibles were more likely than those without deductibles to receive SUD treatment. Exchange enrollment compared to other mechanisms was associated with less ED use. Psychiatric comorbidity was associated with greater use of all services. Nonwhite patients were less likely to initiate SUD and psychiatry treatment.ConclusionsHigher deductibles generally were associated with use of fewer health services, especially in combination with enrollment through the Exchange. The role of insurance factors, psychiatric comorbidity and race/ethnicity in health services for people with SUDs are important to consider as health policy evolves.
- Published
- 2020
23. Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study
- Author
-
Brown, Qiana L., Shmulewitz, Dvora, Sarvet, Aaron L., Young-Wolff, Kelly C., Howard, Tyriesa, and Hasin, Deborah S.
- Published
- 2023
- Full Text
- View/download PDF
24. Trends and correlates of self-reported alcohol and nicotine use among women before and during pregnancy, 2009–2017
- Author
-
Young-Wolff, Kelly C, Sarovar, Varada, Alexeeff, Stacey E, Adams, Sara R, Tucker, Lue-Yen, Conway, Amy, Ansley, Deborah, Goler, Nancy, Armstrong, Mary Anne, and Weisner, Constance
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Substance Misuse ,Drug Abuse (NIDA only) ,Tobacco Smoke and Health ,Pediatric ,Alcoholism ,Alcohol Use and Health ,Perinatal Period - Conditions Originating in Perinatal Period ,Tobacco ,Brain Disorders ,Clinical Research ,Prevention of disease and conditions ,and promotion of well-being ,3.1 Primary prevention interventions to modify behaviours or promote wellbeing ,Reproductive health and childbirth ,Good Health and Well Being ,Adult ,Alcohol Drinking ,Cross-Sectional Studies ,Educational Status ,Ethanol ,Female ,Humans ,Nicotine ,Pregnancy ,Pregnancy Complications ,Pregnant Women ,Prenatal Care ,Prevalence ,Self Report ,Substance-Related Disorders ,Tobacco Smoking ,Young Adult ,Alcohol ,Prenatal ,Trends ,Women ,Screening ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Substance Abuse ,Biochemistry and cell biology ,Pharmacology and pharmaceutical sciences ,Epidemiology - Abstract
ObjectiveTo examine trends and correlates of frequency of self-reported alcohol and nicotine use among pregnant women.MethodsCross-sectional study of 363,240 pregnancies from 2009 to 2017 screened for self-reported substance use at their first prenatal visit in Kaiser Permanente Northern California. Poisson regression with a log link function was used to estimate the annual prevalences of self-reported daily, weekly, and ≤ monthly alcohol and nicotine use, adjusting for socio-demographics. Generalized estimating equation models were used to estimate the adjusted odds ratios (aOR) of any self-reported prenatal alcohol or nicotine use among those who self-reported use in the year prior to pregnancy, by frequency of pre-pregnancy substance use and socio-demographics.ResultsThe sample was 64 % non-White [mean (SD) age = 30.1 (5.6)]. From 2009-2017, alcohol use before pregnancy increased from 63.4%-65.9% (trend p-value = .008), and prenatal alcohol use decreased from 11.6%-8.8% (trend p-value
- Published
- 2020
25. Online patient-provider cannabis consultations
- Author
-
Gali, Kathleen, Narode, Ruth, Young-Wolff, Kelly C, Rubinstein, Mark L, Rutledge, Geoffrey, and Prochaska, Judith J
- Subjects
Health Services and Systems ,Health Sciences ,Clinical Research ,Mental health ,Good Health and Well Being ,Cannabis ,Humans ,Medical Marijuana ,Mental Disorders ,Neoplasms ,Pain ,Palliative Care ,Referral and Consultation ,United States ,Human Movement and Sports Sciences ,Public Health and Health Services ,Public Health ,Epidemiology ,Public health - Abstract
Cannabis has been legalized, decriminalized, or medicalized in over half the U.S. states. With restrictions on cannabis research, accepted standards to guide clinical practice are lacking. Analyzing online communications through a digital health platform, we characterized patient questions about cannabis use and provider responses. Coded for content were 4579 questions posted anonymously online between March 2011 through January 2017, and the responses from 1439 U.S. licensed clinicians. Provider responses to medical cannabis use questions were coded for sentiment: "negative", "positive", and "mixed." Responses could be "thanked" by patients and receive "agrees" from providers. The most frequent themes were detection of cannabis use (25.3%), health harms (19.9%), co-use with other substances (9.1%), and medical use (8.2%). The 425 medical cannabis use questions most frequently related to treatment of mental illness (20.3%), pain (20.0%), and cancer care (6.7%). The 762 provider responses regarding medical cannabis use were coded for sentiment as 59.6% negative, 28.6% mixed, and 11.8% positive. Provider sentiment was most positive regarding cannabis use for palliative care and most negative for treating respiratory conditions, poor appetite, and mental illness. The proportion of positive sentiment responses increased from 17.6% to 32.4%. Provider responses coded as negative sentiment received more provider "Agrees" (mean rank = 280) than those coded as positive (mean rank = 215), beta coefficient = 0.33; 95% CI: 0.05, 0.62; p = .02. Cannabis use is a health topic of public interest. Variability in provider responses reflects the need for more research and consensus building to inform evidence-based clinical guidelines for cannabis use in medicine.
- Published
- 2020
26. Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System
- Author
-
Mangurian, Christina, Schillinger, Dean, Newcomer, John W, Vittinghoff, Eric, Essock, Susan, Zhu, Zheng, Dyer, Wendy, Young-Wolff, Kelly C, and Schmittdiel, Julie
- Subjects
Health Services and Systems ,Biomedical and Clinical Sciences ,Health Sciences ,Diabetes ,Clinical Trials and Supportive Activities ,Prevention ,Clinical Research ,Mental Health ,Schizophrenia ,Brain Disorders ,Cardiovascular ,Serious Mental Illness ,Metabolic and endocrine ,Good Health and Well Being ,Adult ,Delivery of Health Care ,Diabetes Mellitus ,Humans ,Hypertension ,Mental Disorders ,Retrospective Studies ,diabetes ,severe mental illness ,healthcare delivery system ,health outcomes ,Clinical Sciences ,General & Internal Medicine ,Clinical sciences ,Health services and systems ,Public health - Abstract
BackgroundDiabetes prevalence is twice as high among people with severe mental illness (SMI) when compared to the general population. Despite high prevalence, care outcomes are not well understood.ObjectiveTo compare diabetes health outcomes received by people with and without comorbid SMI, and to understand demographic factors associated with poor diabetes control among those with SMI.DesignRetrospective cohort study PARTICIPANTS: 269,243 adults with diabetes MAIN MEASURES: Primary outcomes included optimal glycemic control (A1c < 7) or poor diabetes control (A1c > 9) in 2014. Secondary outcomes included control of other cardiometabolic risk factors (hypertension, dyslipidemia, smoking) and recommended diabetes monitoring.Key resultsAmong this cohort, people with SMI (N = 4,399), compared to those without SMI (N = 264,844), were more likely to have optimal glycemic control, adjusting for various covariates (adjusted relative risk (aRR) 1.25, 95% CI 1.21-1.28, p < .001) and less likely to have poor control (aRR 0.92, 95% CI 0.87-0.98, p = 0.012). Better blood pressure and lipid control was more prevalent among people with SMI when compared to those without SMI (aRR 1.03; 95% CI 1.02-1.05, p < .001; aRR 1.02; 95% CI 1.00-1.05, p = 0.044, respectively). No differences were observed in recommended A1c or LDL testing, but people with SMI were more likely to have blood pressure checked (aRR 1.02, 95% CI 1.02-1.03, p < .001) and less likely to receive retinopathy screening (aRR 0.80, 95% CI 0.71-0.91, p < .001) than those without SMI. Among people with diabetes and comorbid SMI, younger adults and Hispanics were more likely to have poor diabetes control.ConclusionsAdults with diabetes and comorbid SMI had better cardiometabolic control than people with diabetes who did not have SMI, despite lower rates of retinopathy screening. Among those with comorbid SMI, younger adults and Hispanics were more vulnerable to poor A1c control.
- Published
- 2020
27. Routes of cannabis administration among females in the year before and during pregnancy: Results from a pilot project
- Author
-
Young-Wolff, Kelly C, Adams, Sara R, Wi, Sharon, Weisner, Constance, and Conway, Amy
- Subjects
Clinical Research ,Drug Abuse (NIDA only) ,Clinical Trials and Supportive Activities ,Prevention ,Tobacco ,Tobacco Smoke and Health ,Substance Misuse ,Reproductive health and childbirth ,Good Health and Well Being ,Adolescent ,Adult ,California ,Cannabis ,Drug Administration Routes ,Female ,Humans ,Marijuana Smoking ,Middle Aged ,Pilot Projects ,Plants ,Edible ,Pregnancy ,Prevalence ,Self Report ,Skin Cream ,Vaping ,Young Adult ,Public Health and Health Services ,Psychology ,Substance Abuse - Abstract
Use of cannabis during pregnancy is on the rise, yet little is known about how women administer cannabis during the perinatal period. This study examined self-reported modes of cannabis administration among women in the year before and during pregnancy, and their association with self-reported cannabis use frequency using data from 585 women screened in 2018-2019 for cannabis use during standard prenatal care in two medical centers in Northern California. The prevalence of cannabis use was 12% before pregnancy and 3% during pregnancy. Among the 71 women who reported cannabis use before pregnancy and the 19 women who reported cannabis use during pregnancy, smoking was the most common mode of administration (58% and 42%), followed by edibles (27% and 16%), vaping (23% and 16%), lotions (11% and 5%), and other (10% and 0%). In the year before pregnancy and during pregnancy, monthly or less use was most common (56% and 58%), followed by weekly use (24% and 26%) and daily use (20% and 16%). Among cannabis users, 43% used more than one mode before pregnancy compared to 15% during pregnancy. Daily cannabis use was most common among women who reported smoking only or smoking in combination with other modes. These novel results indicate that while smoking is the most common mode of cannabis administration during the perinatal period, there is variation in use and co-use of alternative modes. Future studies are needed to understand the relative health effects associated with individual and combined modes of cannabis administration during pregnancy.
- Published
- 2020
28. The effect of the COVID-19 pandemic on prenatal cannabis use by pre-conception depression and anxiety status
- Author
-
Avalos, Lyndsay A., Ray, G. Thomas, Alexeeff, Stacey E., Adams, Sara R., Does, Monique, Ansley, Deborah, Tucker, Lue-Yen, Conway, Amy, Ettenger, Allison, Goler, Nancy, and Young-Wolff, Kelly C.
- Published
- 2022
- Full Text
- View/download PDF
29. Adverse childhood experiences, mental health, substance use, and HIV-related outcomes among persons with HIV
- Author
-
Young-Wolff, Kelly C, Sarovar, Varada, Sterling, Stacy A, Leibowitz, Amy, McCaw, Brigid, Hare, Charles B, Silverberg, Michael J, and Satre, Derek D
- Subjects
Clinical and Health Psychology ,Health Services and Systems ,Public Health ,Health Sciences ,Psychology ,Health Services ,HIV/AIDS ,Alcoholism ,Alcohol Use and Health ,Mental Health ,Substance Misuse ,Prevention ,Infectious Diseases ,Brain Disorders ,Clinical Research ,Behavioral and Social Science ,Mind and Body ,Evaluation of treatments and therapeutic interventions ,Management of diseases and conditions ,7.1 Individual care needs ,6.1 Pharmaceuticals ,Mental health ,Good Health and Well Being ,Adolescent ,Adult ,Adverse Childhood Experiences ,Aged ,Anxiety ,Child ,Cross-Sectional Studies ,Depression ,Female ,HIV Infections ,Humans ,Longitudinal Studies ,Male ,Middle Aged ,Prevalence ,Quality of Life ,San Francisco ,Substance-Related Disorders ,Young Adult ,Adverse childhood experiences ,quality of life ,HIV ,alcohol ,epidemiology ,trauma ,anxiety ,Public Health and Health Services ,Public health ,Sociology ,Clinical and health psychology - Abstract
While persons with HIV (PWH) have benefited from significant advances in treatment and resulting longevity, mental health problems remain elevated in this population. Adverse childhood experiences (ACEs) are common among PWH and may negatively affect mental health and HIV-related outcomes. We examined the association between ACEs, depression and anxiety symptoms, substance use, antiretroviral therapy (ART) adherence, and HIV-clinical indicators in a sample of 584 PWH at risk for unhealthy alcohol use enrolled in a primary care-based alcohol intervention study. The sample was 96.9% male, 63.0% non-Hispanic white, with an average age of 49.0 years. ACEs were highly prevalent: 82.5% reported ≥1 ACE, including 34.2% reporting 1-2 ACEs, 25.0% reporting 3-4 ACEs, and 23.3% reporting ≥5 ACEs. Adjusting for demographics, having 1-2, 3-4 or ≥5 ACEs was significantly associated with anxiety (ORs (95%CI): 3.41 (1.13-10.33), 4.36 (1.42-3.36), and 3.96 (1.28-12.19), respectively) and poorer mental health quality of life (Betas (SE): -3.21 (1.40), -6.23 (1.51), and -7.09 (1.54), respectively), but not with other outcomes. Trauma-informed interventions to reduce anxiety and improve mental health quality of life in PWH may reduce the negative health sequelae of ACEs.
- Published
- 2019
30. Disparities in knowledge and use of tobacco treatment among smokers in California following healthcare reform
- Author
-
Young-Wolff, Kelly C, Adams, Sara R, Tan, Andy SL, Adams, Alyce S, Klebaner, Daniella, Campbell, Cynthia I, Satre, Derek D, Salloum, Ramzi G, Carter-Harris, Lisa, and Prochaska, Judith J
- Subjects
Public Health ,Health Sciences ,Women's Health ,Behavioral and Social Science ,Tobacco ,Health Services ,Clinical Research ,Prevention ,Health Disparities ,Tobacco Smoke and Health ,Substance Misuse ,Cancer ,Respiratory ,Cardiovascular ,Stroke ,Good Health and Well Being ,Smoking ,Disparities ,Light smokers ,Non-daily smokers ,Spanish-speaking ,Affordable Care Act ,Health reform ,Public Health and Health Services ,Epidemiology ,Health services and systems ,Public health - Abstract
The Affordable Care Act (ACA) promised to narrow smoking disparities by expanding access to healthcare and mandating comprehensive coverage for tobacco treatment starting in 2014. We examined whether two years after ACA implementation disparities in receiving clinician advice to quit and smokers' knowledge and use of treatment resources remained. We conducted telephone interviews in 2016 with a stratified random sample of self-reported smokers newly enrolled in the Kaiser Permanente Northern California's (KPNC) integrated healthcare delivery system in 2014 (N = 491; 50% female; 53% non-white; 6% Spanish language). We used Poisson regression with robust standard errors to test whether sociodemographics, insurance type, comorbidities, smoking status in 2016 (former, light/nondaily [
- Published
- 2019
31. Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009–2016
- Author
-
Young-Wolff, Kelly C, Sarovar, Varada, Tucker, Lue-Yen, Avalos, Lyndsay A, Alexeeff, Stacey, Conway, Amy, Armstrong, Mary Anne, Weisner, Constance, Campbell, Cynthia I, and Goler, Nancy
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Clinical Research ,Prevention ,Drug Abuse (NIDA only) ,Pediatric ,Substance Misuse ,Reproductive health and childbirth ,Good Health and Well Being ,Adolescent ,Adult ,California ,Child ,Cross-Sectional Studies ,Female ,Humans ,Marijuana Use ,Morning Sickness ,Nausea ,Pregnancy ,Pregnant Women ,Prenatal Care ,Prevalence ,Surveys and Questionnaires ,Vomiting ,Young Adult ,Marijuana ,Cannabis ,Nausea and vomiting ,Morning sickness ,Longitudinal ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Substance Abuse ,Biochemistry and cell biology ,Pharmacology and pharmaceutical sciences ,Epidemiology - Abstract
BACKGROUND:Cross-sectional studies indicate an elevated prevalence of prenatal marijuana use in women with nausea and vomiting in pregnancy (NVP). However, it is unknown whether differences in marijuana use by NVP status have persisted over time as marijuana becomes more acceptable and accessible and prenatal use increases overall. We compared trends in prenatal marijuana use by NVP status in the first trimester of pregnancy using data from Kaiser Permanente Northern California's (KPNC) large healthcare system. METHODS:The sample comprised KPNC pregnant women aged ≥12 who completed a self-administered questionnaire on marijuana use and a urine toxicology test for cannabis during standard prenatal care from 2009 to 2016. The annual prevalence of marijuana use via self-report or toxicology by NVP status was estimated using Poisson regression with a log link function, adjusting for sociodemographics and parity. We tested for linear trends and differences in trends by NVP. RESULTS:Of 220,510 pregnancies, 38,831 (17.6%) had an NVP diagnosis. Prenatal marijuana use was elevated each year among women with NVP. The adjusted prevalence of use increased significantly from 2009 to 2016 at an annual rate of 1.086 (95%CI = 1.069-1.104) among women with NVP, from 6.5% (95%CI = 5.7%-7.2%) to 11.1% (95%CI = 0.2%-12.0%), and 1.069 (95%CI = 1.059-1.080) among women without NVP, from 3.4% (95%CI = 3.2%-3.7%) to 5.8% (95%CI = 5.5%-6.1%). Trends did not vary by NVP status. DISCUSSION:The prevalence of prenatal marijuana use has remained elevated over time among women with NVP. Clinicians should ask pregnant patients about their reasons for marijuana use and treat NVP with evidence-based interventions.
- Published
- 2019
32. Characteristics of patients with substance use disorder before and after the Affordable Care Act
- Author
-
Campbell, Cynthia I, Parthasarathy, Sujaya, Altschuler, Andrea, Young-Wolff, Kelly C, and Satre, Derek D
- Subjects
Health Services and Systems ,Biomedical and Clinical Sciences ,Health Sciences ,Substance Misuse ,Clinical Research ,Drug Abuse (NIDA only) ,Women's Health ,Health Services ,Health Disparities ,Brain Disorders ,8.1 Organisation and delivery of services ,Mental health ,Good Health and Well Being ,Adult ,Delivery of Health Care ,Electronic Health Records ,Female ,Health Policy ,Humans ,Insurance Coverage ,Male ,Medicaid ,Middle Aged ,Patient Protection and Affordable Care Act ,Substance-Related Disorders ,United States ,Affordable Care Act ,Substance use disorder ,Mixed methods ,Electronic health record ,Health Insurance ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Substance Abuse ,Biochemistry and cell biology ,Pharmacology and pharmaceutical sciences ,Epidemiology - Abstract
BackgroundThe Affordable Care Act (ACA) offered an unprecedented opportunity to expand insurance coverage to patients with substance use disorders (SUDs). We explored the expectations of key stakeholders for the ACA's impact on SUD care, and examined how clinical characteristics of newly enrolled patients with SUD in a large healthcare delivery system differed pre- and post- ACA implementation.MethodsIn this mixed-methods study, qualitative interviews were conducted with health system leaders to identify themes regarding how the health system prepared for the ACA. Electronic health record data were used to examine demographics, as well as specific SUD, psychiatric, and medical diagnoses in cohorts of pre-ACA (2012, n = 6066) vs. post-ACA (2014, n = 7099) newly enrolled patients with SUD. Descriptive statistics and logistic regression models were employed to compare pre-ACA and post-ACA measures.ResultsInterviewees felt much uncertainty, but anticipated having to care for more SUD patients, who might have greater severity. Quantitative findings affirmed these expectations, with post-ACA SUD patients having higher rates of cannabis and amphetamine use disorders, and more psychiatric and medical conditions, compared to their pre-ACA counterparts. The post-ACA SUD cohort also had more Medicaid patients and greater enrollment in high-deductible plans.ConclusionsPost-ACA, SUD patients had more comorbidities as well as and more financial barriers to care. As federal healthcare policy continues to evolve, with potentially more restrictive coverage criteria, it is essential to continue examining how health systems adapt to changing health policy and its impact on SUD care.
- Published
- 2018
33. Evaluating the Impact of Eliminating Copayments for Tobacco Cessation Pharmacotherapy
- Author
-
Young-Wolff, Kelly C, Adams, Sara R, Klebaner, Daniella, Adams, Alyce S, Campbell, Cynthia I, Satre, Derek D, and Prochaska, Judith J
- Subjects
Public Health ,Health Sciences ,Tobacco Smoke and Health ,Clinical Research ,Prevention ,Tobacco ,Cancer ,Good Health and Well Being ,Adolescent ,Adult ,Aged ,California ,Deductibles and Coinsurance ,Female ,Humans ,Income ,Male ,Middle Aged ,Patient Protection and Affordable Care Act ,Smoking Cessation ,Socioeconomic Factors ,Tobacco Use Cessation ,Tobacco Use Cessation Devices ,Young Adult ,Affordable Care Act ,tobacco cessation pharmacotherapy ,smoking ,tobacco treatment ,integrated healthcare ,copayment ,cost-sharing ,disparities ,income ,Public Health and Health Services ,Applied Economics ,Health Policy & Services ,Applied economics ,Health services and systems ,Policy and administration - Abstract
ObjectivesWe examined the impact of the Affordable Care Act-mandated elimination of tobacco cessation pharmacotherapy (TCP) copayments on patient use of TCP, overall and by income.MethodsElectronic health record data captured any and combination (eg, nicotine gum plus patch) TCP use among adult smokers newly enrolled in Kaiser Permanente Northern California (KPNC). KPNC eliminated TCP copayments in 2015. We included current smokers newly enrolled in the first 6 months of 2014 (before copayment elimination, N=16,199) or 2015 (after elimination, N=16,469). Multivariable models estimated 1-year changes in rates of any TCP fill, and of combination TCP fill, and tested for differences by income (
- Published
- 2018
34. Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study
- Author
-
Avalos, Lyndsay A., Adams, Sara R., Alexeeff, Stacey E., Oberman, Nina R., Does, Monique B., Ansley, Deborah, Goler, Nancy, Padon, Alisa A., Silver, Lynn D., and Young-Wolff, Kelly C.
- Published
- 2024
- Full Text
- View/download PDF
35. Evaluation of an Embedded Health Psychologist Intervention for Obstetric Patients With Adverse Childhood Experiences.
- Author
-
Watson, Carey R., Wei, Julia, Rios, Normelena, Staunton, Mary, Koper, Anna, Shiels, Jacqueline, Lee, Nina, and Young-Wolff, Kelly C.
- Subjects
PREGNANT women ,ADVERSE childhood experiences ,PRENATAL care ,ODDS ratio ,LOGISTIC regression analysis - Abstract
BACKGROUND: Screening for adverse childhood experiences (ACEs) and resilience in pregnancy is a promising practice for mitigating ACEs-related health complications. Yet, the best follow-up for pregnant patients with high ACEs and/or low resilience has not been established. OBJECTIVE: This study evaluates referrals to and participation in an embedded health psychologist (EHP) intervention for pregnant patients with ACEs and/or low resilience. MATERIALS AND METHODS: Patients in 3 Kaiser Permanente Northern California medical centers with ACEs who had also received resilience screening during standard prenatal care and who were participating in an EHP intervention were included (N = 910). The authors used multivariable logistic regression to examine whether ACEs (0, 1-2, 3+) and resilience (high vs low) were associated with referrals to and participation in EHP intervention. They also evaluated the impact of EHP intervention through clinician (N = 53) and patient (N = 51) surveys. RESULTS: Patients with 3+ vs 0 ACEs were more likely to receive an EHP referral (adjusted odds ratio [aOR] = 2.89, 95% confidence interval [CI]: 1.93-4.33) and were more likely to participate in EHP intervention (aOR = 2.85, 95% CI: 1.87-4.36). Those with low vs high resilience were also more likely to receive an EHP referral (aOR = 1.86, 95% CI: 1.32-2.62) and participate in EHP (aOR = 1.71, 95% CI: 1.19-2.44). When ACEs and resilience were combined, those with high ACEs and low resilience had the greatest odds of referrals and participation. Patients and clinicians reported positive experiences with EHP intervention. CONCLUSION: Patients with higher ACEs and lower resilience scores were more likely to be referred to and participate in EHP intervention, suggesting that at-risk patients can be successfully linked with a health psychologist when accessible within obstetric care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Representativeness of Patients With Lung Cancer in an Integrated Health Care Delivery System.
- Author
-
Yang, Mike Z., Liu, Raymond, Von Behren, Julie, Lin, Katherine, Adams, Alyce S., Kushi, Lawrence H., Quesenberry Jr, Charles P., Velotta, Jeffrey B., Wong, Melisa L., Young-Wolff, Kelly C., Gomez, Scarlett L., Shariff-Marco, Salma, and Sakoda, Lori C.
- Subjects
INTEGRATED health care delivery ,ELECTRONIC health records ,WATERSHEDS ,AIR pollution ,MINORITIES - Abstract
Introduction: Observational research is important for understanding the real-world benefits of advancements in lung cancer care. Integrated health care systems, such as Kaiser Permanente Northern California, have extensive electronic health records suitable for such research, but the generalizability of their populations is often questioned. Methods: Leveraging data from the California Cancer Registry, the authors compared distributions of demographic and clinical characteristics, in addition to neighborhood and environmental conditions, between patients diagnosed with lung cancer from 2015 through 2019 at Kaiser Permanente Northern California, National Cancer Institute-designated cancer centers (NCICCs), and all other non-N CICC hospitals within the same catchment area. Results: Of 20,178 included patients, 30% were from Kaiser Permanente Northern California, 8% from NCICCs, and 62% from other non-N CICC hospitals. Compared to NCICC patients, Kaiser Permanente Northern California patients were more similar to other non-N CICC patients on most characteristics. Compared to other non-N CICC patients, Kaiser Permanente Northern California patients were slightly older, more likely to be female, and less likely to be Hispanic or Asian/Pacific Islander and to reside in lower socioeconomic status (SES) neighborhoods. In contrast, NCICC patients were younger, less likely to be female or from non-A sian/Pacific Islander minoritized racial groups, and more likely to present with early-stage disease and adenocarcinoma and to reside in neighborhoods with higher SES and lower air pollution than Kaiser Permanente Northern California or other non-N CICC patients. Discussion: Patients from Kaiser Permanente Northern California, compared to NCICCs, are more broadly representative of the underlying patient population with lung cancer. Conclusion: Research using electronic health record data from integrated health care systems can contribute generalizable real-world evidence to benchmark and improve lung cancer care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Prenatal Cannabis Use and Maternal Pregnancy Outcomes.
- Author
-
Young-Wolff, Kelly C., Adams, Sara R., Alexeeff, Stacey E., Zhu, Yeyi, Chojolan, Edwin, Slama, Natalie E., Does, Monique B., Silver, Lynn D., Ansley, Deborah, Castellanos, Carley L., and Avalos, Lyndsay A.
- Published
- 2024
- Full Text
- View/download PDF
38. Documentation of e-cigarette use and associations with smoking from 2012 to 2015 in an integrated healthcare delivery system
- Author
-
Young-Wolff, Kelly C, Klebaner, Daniella, Folck, Bruce, Tan, Andy SL, Fogelberg, Renee, Sarovar, Varada, and Prochaska, Judith J
- Subjects
Health Services and Systems ,Health Sciences ,Electronic Nicotine Delivery Systems ,Substance Misuse ,Tobacco ,Clinical Research ,Tobacco Smoke and Health ,Prevention ,Drug Abuse (NIDA only) ,Cancer ,Respiratory ,Good Health and Well Being ,Adolescent ,Adult ,Aged ,California ,Cross-Sectional Studies ,Delivery of Health Care ,Integrated ,Female ,Humans ,Male ,Middle Aged ,Retrospective Studies ,Smoking ,Smoking Cessation ,Surveys and Questionnaires ,Vaping ,Young Adult ,e-Cigarette ,ENDS ,Cigarettes ,Electronic health record ,EHR ,Provider documentation ,Clinician ,Human Movement and Sports Sciences ,Public Health and Health Services ,Public Health ,Epidemiology ,Public health - Abstract
It is unclear whether use of electronic nicotine delivery systems (ENDS) precedes cigarette smoking initiation, relapse, and/or quitting. Healthcare systems with electronic health records (EHRs) provide unique data to examine ENDS use and changes in smoking. We examined the incidence of ENDS use (2012-2015) based on clinician documentation and tested whether EHR documented ENDS use is associated with twelve-month changes in patient smoking status using a matched retrospective cohort design. The sample was Kaiser Permanente Northern California (KPNC) patients aged ≥12 with documented ENDS use (N = 7926); 57% were current smokers, 35% former smokers, and 8% never-smokers. ENDS documentation incidence peaked in 2014 for current and former smokers and in 2015 for never-smokers. We matched patients with documented ENDS use to KPNC patients without documented ENDS use (N = 7926) on age, sex, race/ethnicity, and smoking status. Documented ENDS use predicted the likelihood of smoking in the following year. Among current smokers, ENDS use was associated with greater odds of quitting smoking (OR = 1.17, 95%CI = 1.05-1.31). Among former smokers, ENDS use was associated with greater odds of smoking relapse (OR = 1.53, 95%CI = 1.22-1.92). Among never-smokers, ENDS use was associated with greater odds of initiating smoking (OR = 7.41, 95%CI = 3.14-17.5). The overall number of current smokers at 12 months was slightly higher among patients with (N = 3931) versus without (N = 3850) documented ENDS use. Results support both potential harm reduction of ENDS use (quitting combustibles among current smokers) and potential for harm (relapse to combustibles among former smokers, initiation for never-smokers).
- Published
- 2018
39. Alcohol, Marijuana, and Opioid use Disorders: 5-Year Patterns and Characteristics of Emergency Department Encounters
- Author
-
Bahorik, Amber L, Satre, Derek D, Kline-Simon, Andrea H, Weisner, Constance M, Young-Wolff, Kelly C, and Campbell, Cynthia I
- Subjects
Health Services and Systems ,Public Health ,Health Sciences ,Drug Abuse (NIDA only) ,Emergency Care ,Brain Disorders ,Alcoholism ,Alcohol Use and Health ,Clinical Research ,Substance Misuse ,Health Services ,Mental health ,Good Health and Well Being ,Adult ,Alcoholism ,California ,Case-Control Studies ,Emergency Service ,Hospital ,Female ,Humans ,Male ,Marijuana Use ,Opioid-Related Disorders ,Patient Admission ,Retrospective Studies ,Young Adult ,Access/demand/utilization of services ,administrative data uses ,managed care organizations ,mental health ,substance abuse ,Public Health and Health Services ,Psychology ,Substance Abuse ,Health services and systems ,Public health ,Clinical and health psychology - Abstract
BackgroundChanges in substance use patterns stemming from opioid misuse, ongoing drinking problems, and marijuana legalization may result in new populations of patients with substance use disorders (SUDs) using emergency department (ED) resources. This study examined ED admission trends in a large sample of patients with alcohol, marijuana, and opioid use disorders in an integrated health system.MethodsIn a retrospective design, electronic health record (EHR) data identified patients with ≥1 of 3 common SUDs in 2010 (n = 17,574; alcohol, marijuana, or opioid use disorder) and patients without SUD (n = 17,574). Logistic regressions determined odds of ED use between patients with SUD versus controls (2010-2014); mixed-effect models examined 5-year differences in utilization; moderator models identified subsamples for which patients with SUD may have a greater impact on ED resources.ResultsOdds of ED use were higher at each time point (2010-2014) for patients with alcohol (odds ratio [OR] range: 5.31-2.13, Ps < .001), marijuana (OR range: 5.45-1.97, Ps < .001), and opioid (OR range: 7.63-4.19, Ps < .001) use disorders compared with controls; odds decreased over time (Ps < .001). Patients with opioid use disorder were at risk of high ED utilization; patients were 7.63 times more likely to have an ED visit in 2010 compared with controls and remained 5.00 (average) times more likely to use ED services. ED use increased at greater rates for patients with alcohol and opioid use disorders with medical comorbidities relative to controls (Ps < .045).ConclusionsED use is frequent in patients with SUDs who have access to private insurance coverage and integrated medical services. ED settings provide important opportunities in health systems to identify patients with SUDs, particularly patients with opioid use disorder, to initiate treatment and facilitate ongoing care, which may be effective for reducing excess medical emergencies and ED encounters.
- Published
- 2018
40. Do you vape? Leveraging electronic health records to assess clinician documentation of electronic nicotine delivery system use among adolescents and adults
- Author
-
Young-Wolff, Kelly C, Klebaner, Daniella, Folck, Bruce, Carter-Harris, Lisa, Salloum, Ramzi G, Prochaska, Judith J, Fogelberg, Renee, and Tan, Andy SL
- Subjects
Health Services and Systems ,Health Sciences ,Clinical Research ,Networking and Information Technology R&D (NITRD) ,Cancer ,Tobacco ,Electronic Nicotine Delivery Systems ,Patient Safety ,Behavioral and Social Science ,Prevention ,Health Services ,Tobacco Smoke and Health ,Good Health and Well Being ,Adolescent ,Adult ,Child ,Documentation ,Electronic Health Records ,Humans ,Male ,Natural Language Processing ,Vaping ,Electronic nicotine delivery systems ,Electronic health record ,Integrated healthcare ,Natural language processing ,Adolescents ,Clinicians ,E-cigarettes ,Semantics ,Human Movement and Sports Sciences ,Public Health and Health Services ,Public Health ,Epidemiology ,Public health - Abstract
Use of electronic nicotine delivery systems (ENDS) has increased substantially over the past decade. However, unlike smoking, which is systematically captured by clinicians through routine screening and discrete documentation fields in the electronic health record (EHR), unknown is the extent to which clinicians are documenting patients' use of ENDS. Data were gathered from medical visits with patients aged 12 and older (N=9,119; 55% male) treated in a large, integrated healthcare system. We used natural language processing to assess the incidence rates of clinician documentation of patients' ENDS use in unstructured tobacco comments in the EHR, and the words most frequently documented in relation to ENDS, from 2006-2015. ENDS documentation in the EHR increased dramatically over time (from 0.01 to 9.5 per 10,000 patients, p
- Published
- 2017
41. Association of Adverse Childhood Experiences and Resilience With Depression and Anxiety During Pregnancy
- Author
-
Watson, Carey R., primary, Eaton, Abigail, additional, Campbell, Cynthia I., additional, Alexeeff, Stacey E., additional, Avalos, Lyndsay A., additional, Ridout, Kathryn K., additional, and Young-Wolff, Kelly C., additional
- Published
- 2024
- Full Text
- View/download PDF
42. Why do Americans use marijuana?
- Author
-
Kurtzman, Ellen T. and Young-Wolff, Kelly C.
- Published
- 2021
- Full Text
- View/download PDF
43. The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system
- Author
-
Satre, Derek D., Levine-Hall, Tory, Sterling, Stacy A., Young-Wolff, Kelly C., Lam, Jennifer O., Alexeeff, Stacey, Hojilla, J. Carlo, Williams, Andrew, Justice, Amy C., Sterne, Jonathan, Cavassini, Matthias, Bryant, Kendall J., Williams, Emily C., Horberg, Michael A., Volberding, Paul, Weisner, Constance, and Silverberg, Michael J.
- Published
- 2021
- Full Text
- View/download PDF
44. Association of the Affordable Care Act With Smoking and Tobacco Treatment Utilization Among Adults Newly Enrolled in Health Care
- Author
-
Young-Wolff, Kelly C, Klebaner, Daniella, Campbell, Cynthia I, Weisner, Constance, Satre, Derek D, and Adams, Alyce S
- Subjects
Health Services and Systems ,Health Sciences ,Health Services ,Prevention ,Tobacco Smoke and Health ,Clinical Research ,Tobacco ,Cancer ,Respiratory ,Stroke ,Good Health and Well Being ,Adult ,Female ,Health Services Accessibility ,Health Services Needs and Demand ,Humans ,Insurance Coverage ,Male ,Medicaid ,Middle Aged ,Patient Protection and Affordable Care Act ,Smoking Prevention ,Tobacco Use Cessation ,Tobacco Use Disorder ,United States ,smoking ,tobacco treatment ,health care reform ,Affordable Care Act ,integrated health care ,Public Health and Health Services ,Applied Economics ,Health Policy & Services ,Applied economics ,Health services and systems ,Policy and administration - Abstract
ObjectivesTo examine rates of smoking and tobacco treatment utilization by insurance coverage status (Medicaid, commercial, exchange) among newly enrolled patients in the post Affordable Care Act (ACA) era.MethodsWe examined new members who enrolled in Kaiser Permanente Northern California through Medicaid, the California exchange, or nonexchange commercial plans (N=122,298) in the first 6 months of 2014 following ACA implementation. We compared these groups on smoking prevalence and tested whether smokers in each group differed on sociodemographic characteristics and in their utilization of tobacco treatment (pharmacotherapy and counseling) in 2014.ResultsSmoking prevalence was higher among Medicaid (22%) than exchange (13%) or commercial (12%) patients (P
- Published
- 2017
45. Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.
- Author
-
Campbell, Cynthia I, Parthasarathy, Sujaya, Young-Wolff, Kelly C, and Satre, Derek D
- Subjects
Humans ,Marijuana Abuse ,Opioid-Related Disorders ,Buprenorphine ,Logistic Models ,Adult ,Middle Aged ,Delivery of Health Care ,Integrated ,Health Services Accessibility ,Female ,Male ,Electronic Health Records ,Opiate Substitution Treatment ,Patient Protection and Affordable Care Act ,Affordable Care Act ,buprenorphine ,health services utilization ,Delivery of Health Care ,Integrated ,Drug Abuse ,Brain Disorders ,Neurosciences ,Substance Abuse ,Clinical Research ,Health Services ,8.1 Organisation and delivery of services ,Mental Health ,Public Health and Health Services ,Psychology - Abstract
The Affordable Care Act (ACA) was expected to benefit patients with substance use disorders, including opioid use disorders (OUDs). This study examined buprenorphine use and health services utilization by patients with OUDs pre- and post-ACA in a large health care system. Using electronic health record data, we examined demographic and clinical characteristics (substance use, psychiatric and medical conditions) of two patient cohorts using buprenorphine: those newly enrolled in 2012 ("pre-ACA," N = 204) and in 2014 ("post-ACA," N = 258). Logistic and negative binomial regressions were used to model persistent buprenorphine use, and to examine whether persistent use was related to health services utilization. Buprenorphine patients were largely similar pre- and post-ACA, although more post-ACA patients had a marijuana use disorder (p
- Published
- 2017
46. Smoke-Free Laws and Hazardous Drinking: A Cross-Sectional Study among U.S. Adults.
- Author
-
Jiang, Nan, Gonzalez, Mariaelena, Ling, Pamela M, Young-Wolff, Kelly C, and Glantz, Stanton A
- Subjects
Humans ,Alcoholic Intoxication ,Logistic Models ,Cross-Sectional Studies ,Alcohol Drinking ,Socioeconomic Factors ,Adolescent ,Adult ,Aged ,Middle Aged ,United States ,Female ,Male ,Young Adult ,Smoke-Free Policy ,Binge Drinking ,alcohol ,hazardous drinking ,smoke-free law ,smoking ,Alcoholism ,Alcohol Use and Health ,Substance Abuse ,Tobacco Smoke and Health ,Behavioral and Social Science ,Prevention ,Underage Drinking ,Tobacco ,Pediatric ,3.1 Primary prevention interventions to modify behaviours or promote well-being ,Cancer ,Stroke ,Cardiovascular ,Smoking and Health ,Toxicology - Abstract
Tobacco and alcohol use are strongly associated. This cross-sectional study examined the relationship of smoke-free law coverage and smoke-free bar law coverage with hazardous drinking behaviors among a representative sample of U.S. adult drinkers (n = 17,057). We merged 2009 National Health Interview Survey data, American Nonsmokers' Rights Foundation U.S. Tobacco Control Laws Database, and Census Population Estimates. Hazardous drinking outcomes included heavy drinking (>14 drinks/week for men; >7 drinks/week for women) and binge drinking (≥5 drinks on one or more days during past year). Chi-square tests compared hazardous drinking by sociodemographic factors. Multivariable logistic regression models were used to examine if smoke-free law and bar law coverages were associated with hazardous drinking, controlling for sociodemographics and smoking status. Subset analyses were conducted among drinkers who also smoked (n = 4074) to assess the association between law coverages and hazardous drinking. Among all drinkers, smoke-free law coverage was not associated with heavy drinking (adjusted odds ratio (AOR) = 1.22, 95% confidence interval (CI) = 0.99-1.50) or binge drinking (AOR = 1.09, 95% CI = 0.93-1.26). Smoke-free bar law coverage was also found to be unrelated to hazardous drinking. Similar results were found among those drinkers who smoked. Findings suggest that smoke-free laws and bar laws are not associated with elevated risk for alcohol-related health issues.
- Published
- 2017
47. Smoking, Mental Illness, and Public Health
- Author
-
Prochaska, Judith J, Das, Smita, and Young-Wolff, Kelly C
- Subjects
Health Services and Systems ,Public Health ,Health Sciences ,Prevention ,Behavioral and Social Science ,Tobacco ,Drug Abuse (NIDA only) ,Tobacco Smoke and Health ,Substance Misuse ,3.5 Resources and infrastructure (prevention) ,Prevention of disease and conditions ,and promotion of well-being ,Cardiovascular ,Mental health ,Respiratory ,Cancer ,Stroke ,Good Health and Well Being ,Comorbidity ,Health Policy ,Humans ,Mental Disorders ,Mentally Ill Persons ,Smoking ,Smoking Cessation ,United States ,smoking ,tobacco ,mental illness ,psychiatric ,depression ,substance use ,Public Health and Health Services ,Epidemiology ,Public health - Abstract
Tobacco use remains the leading preventable cause of death worldwide. In particular, people with mental illness are disproportionately affected with high smoking prevalence; they account for more than 200,000 of the 520,000 tobacco-attributable deaths in the United States annually and die on average 25 years prematurely. Our review aims to provide an update on smoking in the mentally ill. We review the determinants of tobacco use among smokers with mental illness, presented with regard to the public health HAVE framework of "the host" (e.g., tobacco user characteristics), the "agent" (e.g., nicotine product characteristics), the "vector" (e.g., tobacco industry), and the "environment" (e.g., smoking policies). Furthermore, we identify the significant health harms incurred and opportunities for prevention and intervention within a health care systems and larger health policy perspective. A comprehensive effort is warranted to achieve equity toward the 2025 Healthy People goal of reducing US adult tobacco use to 12%, with attention to all subgroups, including smokers with mental illness.
- Published
- 2017
48. Association of Local Cannabis Policy and Retail Availability With Cannabis Use and Problematic Cannabis Use Among Adolescents in Northern California.
- Author
-
Young-Wolff, Kelly C., Asera, Alex, Padon, Alisa A., Slama, Natalie E., Alexeeff, Stacey E., Pacula, Rosalie L., Campbell, Cynthia I., Sterling, Stacy A., Satre, Derek D., Lu, Yun, Dyer, Wendy T., Does, Monique B., and Silver, Lynn D.
- Abstract
Objectives. To examine whether local cannabis policies and retail availability are associated with cannabis use and problematic cannabis use (PCU) among adolescents in Northern California. Methods. The sample comprised adolescents aged 13 to 17 years screened for past-year cannabis use during well-child visits in 2021. Exposures included local bans on cannabis storefront retailers, policy protectiveness, and retail proximity and density. Outcomes included self-reported past-year cannabis use and PCU diagnoses. Modified Poisson regression models adjusted for sociodemographics. Results. The sample (n = 103 134) was 51.1% male with a median age of 15 years (interquartile range [IQR] = 14–16 years); 5.5% self-reported cannabis use, and 0.3% had diagnosed PCU. Adolescents had a lower prevalence of cannabis use in jurisdictions that banned storefront retailers (adjusted prevalence rate [APR] = 0.857; 95% confidence interval [CI] = 0.814, 0.903 vs allowed), banned delivery (APR = 0.751; 95% CI = 0.710, 0.795 vs allowed), or had more policy protections (APR range = 0.705–0.800). Lower PCU prevalence was also found among those in jurisdictions that banned (vs allowed) storefront retailers (APR = 0.786; 95% CI = 0.629, 0.983) or delivery (APR = 0.783; 95% CI = 0.616, 0.996). Longer drive time and lower density of storefront retailers were associated with a lower cannabis use prevalence. Conclusions. More protective cannabis policies and less retail availability were associated with a lower prevalence of adolescent cannabis use and PCU. (Am J Public Health. 2024;114(S8):S654–S663. https://doi.org/10.2105/AJPH.2024.307787) [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Association of psychiatric and substance use disorders with cannabis use and cannabis use disorder during early pregnancy in northern California.
- Author
-
Young‐Wolff, Kelly C., Chi, Felicia W., Campbell, Cynthia I., Does, Monique B., Brown, Qiana L., Alexeeff, Stacey E., Ansley, Deborah, Wang, Xiaoming, and Lapham, Gwen T.
- Subjects
- *
SUBSTANCE abuse risk factors , *RISK assessment , *SELF-evaluation , *BIPOLAR disorder , *POST-traumatic stress disorder , *ATTENTION-deficit hyperactivity disorder , *DATA analysis , *RESEARCH funding , *SCIENTIFIC observation , *RETROSPECTIVE studies , *PREGNANT women , *ANXIETY , *DESCRIPTIVE statistics , *ODDS ratio , *URINALYSIS , *ELECTRONIC health records , *STATISTICS , *PSYCHOSES , *CANNABIS (Genus) , *SUBSTANCE abuse in pregnancy , *SOCIODEMOGRAPHIC factors , *DATA analysis software , *CONFIDENCE intervals , *MENTAL depression , *PREGNANCY - Abstract
Aims: To estimate the strength of association between psychiatric disorders and substance use disorders (SUD), and cannabis use and cannabis use disorder (CUD) during early pregnancy. Design: Observational study. Setting: Kaiser Permanente Northern California, USA. Participants: 299 496 pregnancies from 227 555 individuals screened for cannabis use by self‐report and a urine toxicology test at entrance to prenatal care in Kaiser Permanente Northern California during January 2011–December 2021 (excepting year 2020). The sample was 62.5% non‐White, with a mean (standard deviation) age of 31.1 (5.5) years; 6.8% used cannabis; 0.2% had a CUD. Measurements: Exposure variables included electronic health record‐based psychiatric diagnoses of attention deficit hyperactivity, anxiety, bipolar, depressive, personality, posttraumatic stress and psychotic disorders; and alcohol, opioid, stimulant and tobacco use disorders, during the two years prior to pregnancy up to the day before the prenatal substance use screening date. Outcome variables were any cannabis use, frequency of self‐reported cannabis use and CUD during early pregnancy. Findings Psychiatric disorder prevalence ranged from 0.2% (psychotic) to 14.3% (anxiety), and SUD ranged from 0.3% (stimulant/opioid) to 3.8% (tobacco). Psychiatric disorders were associated with cannabis use and CUD, with the strongest association for any use found for bipolar disorder (adjusted odds ratio [aOR] = 2.83; 95% confidence interval [CI] = 2.53–3.17) and the strongest association for CUD found for psychotic disorders (aOR = 10.01, 95% CI = 6.52–15.37). SUDs were associated with cannabis use and CUD, with the strongest association for any use found for tobacco use disorder (aOR = 4.03, 95% CI = 3.82–4.24) and the strongest association for CUD found for stimulant use disorder (aOR = 21.99, 95% CI = 16.53–29.26). Anxiety, bipolar, depressive disorders and tobacco use disorder were associated with greater odds of daily than monthly or less cannabis use. Conclusions: Psychiatric disorders and substance use disorders appear to be associated with elevated odds of any and frequent cannabis use as well as cannabis use disorder during early pregnancy. In most cases, the associations with cannabis outcomes were stronger for substance use disorders than other psychiatric disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system
- Author
-
Satre, Derek D., Palzes, Vanessa A., Young-Wolff, Kelly C., Parthasarathy, Sujaya, Weisner, Constance, Guydish, Joseph, and Campbell, Cynthia I.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.